Quantum-Enhanced CRISPR-Based Epigenome Editing: CRISPR Medicine 2025 Conference Poster Highlight

Research presented at Copenhagen's CRISPRMED25 conference unveils a quantum-enhanced epigenome editing approach that harnesses nitrogen-vacancy centers in diamond nanoparticles to improve TP53 gene demethylation, potentially revolutionizing cancer treatment strategies.

By: BioQuick News - Apr. 12, 2025

One of the most conceptually original and forward-looking posters presented at the 2^nd Annual CRISPR* Medicine 2025 Conference (CRISPRMED25) in Copenhagen was titled “Exploring Quantum-Enhanced CRISPR-Based Epigenome Editing: A Case Study on TP53 Demethylation Using NV-Centered Diamond Nanoparticles.”

The project was officially presented by Asra Hamidi, a Kurdish researcher from Kurdistan, currently serving as a Supervised Research Trainee at Quantum Immunogenix – A Third Eye Network INC (USA). As her visa application was still pending during the conference dates, the poster was presented on her behalf by her supervisor, Dr. Sunil Joshi, who also responded to questions during the session.

This project introduces an innovative in silico framework that integrates quantum entanglement with CRISPR-based epigenome editing—targeting precise demethylation of the TP53 gene, a critical tumor suppressor frequently silenced in a wide range of human cancers. What sets the project apart is its use of quantum entanglement as a core mechanism to enhance molecular targeting accuracy, rather than relying solely on classical biochemical properties.

Read the full article at BioQuick News here.

BioQuick® Online News LLC is dedicated to the timely reporting of key life science and medical advances from around the globe. BioQuick has readers in over 160 countries. BioQuick also has a Japanese-language edition. BioQuick has received prestigious APEX Awards for Publishing Excellence in nine consecutive years. BioQuick currently offers over 8,000 articles on major life science and medical advances of the last ten years, and a total of over 1,000,000 page views in that time. A particular topic can be easily looked for using the publication’s powerful search engine. Recently, BioQuick has been a media partner for a number of major scientific events, including the CRISPR Medicine Conference 2025 and the Precision Medicine World Conference (PMWC) Annual Meeting 2025. BioQuick is actively seeking additional advertising and sponsorship. Mike O’Neill, a long-time award-winning science writer, is the editor & publisher of BioQuick.

To get more CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

ArticleBioQuick NewsNewsCRISPRMED25